Genflow Biosciences plc (LON: GENF)
London
· Delayed Price · Currency is GBP · Price in GBX1.750
+0.275 (18.64%)
Dec 23, 2024, 4:28 PM BST
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 5.16 million as of December 23, 2024. Its market cap has increased by 6.88% in one year.
Market Cap
5.16M
Enterprise Value
4.02M
Revenue
598.04K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.75
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 5.16M, a decrease of -84.67%. That is a compound annual growth rate of -47.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 5.16M | 23.75% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca PLC | 159.00B |
| GSK plc | 53.86B |
| Haleon plc | 34.50B |
| Smith & Nephew plc | 8.48B |
| ConvaTec Group PLC | 4.52B |
| Hikma Pharmaceuticals PLC | 4.33B |
| Oxford Nanopore Technologies plc | 1.37B |
| Animalcare Group plc | 143.09M |